Dr Michael Oefelein will be presenting on behalf of Prokarium at the American Urology Association (AUA) Annual Meeting, Washington, DC, 15-18th May 2026.

Presentation information:

• Presentation Title: PD09-03: PARADIGM 1 – A multi-center Phase 1 study evaluating the safety and clinical effect of a novel microbial immunotherapeutic (ZH9) in patients with relapsed NMIBC – A first interim review

• Session Title: PD09: Bladder Cancer: Non-invasive III

• Session Date and Time: Saturday 16th May, 07:00 – 09:00